Research Report on "
Global Preventive
Asthma Drugs Market 2015-2019 ".
About asthma
According to the Global
Initiative for Asthma, asthma is a chronic disease, which is
characterized by wheezing, shortness of breath, chest tightness, and
cough over a period of time. The symptoms worsen due to the increased
secretion of mucus, bronchoconstriction, and thickening of the walls
of the airways, resulting in difficulty in expiration. According to
the American Academy of Allergy, Asthma, and Immunology, asthma is
classified into four types: exercise-induced, allergic, occupational,
and childhood. Also, asthma can be classified into two categories:
allergic and non-allergic, as per the classification of Asthma and
Allergy Foundation of America. Asthma can be managed by preventive
medications, which should be administered to the patient regularly to
improve his quality of life by controlling the exacerbations.
Technavio's analysts forecast
the global preventive asthma drugs market to grow at a CAGR of 5.20%
over the period 2014-2019.
Download Sample copy of
this Report
Covered in this report
This report covers the present
scenario and the growth prospects of the global preventive asthma
drugs market for 2015-2019. To calculate the market size, the report
considers revenue generated from the sale of the following classes of
drugs used to treat asthma:
- Immunosuppressants
- Leukotriene antagonists
- Mast cell stabilizers
- Corticosteroids
- Combination of LABA/ ICS
This report includes a
discussion of the market in the following three regions:
Americas: The major countries
focused in the Americas are the US, Canada, Mexico, and Brazil
EMEA: The major countries in
this region are the UK, Germany, Italy, France, Spain and Middle
Eastern and African countries such as Israel, South Africa, Egypt,
Sudan, Kuwait, Saudi Arabia, Qatar, and the UAE
APAC: The major countries in
this region are Japan, China, Australia, Singapore, South Korea, and
India
Technavio's report, Global
Preventive Asthma Drugs Market 2015-2019, has been prepared based on
an in-depth market analysis with inputs from industry experts. The
report covers the market landscape of the global preventive asthma
drugs market and its growth prospects in the coming years. The report
includes a discussion of the key vendors operating in this market.
Key regions
- Americas
- APAC
- EMEA
Key vendors
- AstraZeneca
- F. Hoffmann-La Roche
- GlaxoSmithKline
- Merck
- Novartis
Other prominent vendors
- Abbott
- Amgen
- AptarGroup
- Biotest
- Boehringer Ingelheim
Key market driver : High
prevalence of asthma
Key market challenge :
Unknown disease etiology
Key market trend : Growing
popularity of combination therapies
To Get Sample Copy of
Report visit @
http://www.marketresearchreports.biz/analysis-details/global-preventive-asthma-drugs-market-2015-2019
Table
of Content :
PART 01: Executive summary
Highlights
PART 02: Scope of the
report
Market overview
Top-vendor offerings
PART 03: Market research
methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Product profiles
Accolate
Pulmicort
Symbicort
Xolair
Browse Press Releases by
Prweb :
About us
MarketResearchReports.biz is
the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact us:
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free:
866-997-4948
No comments:
Post a Comment